Patients with adenomyosis trended more toward an increased clinical pregnancy rate following FET with GnRH-a pretreatment, compared with fresh ET, but the difference was nonsignificant (39.5% vs. 30.5%, p > 0.05) [22]. This evidence concerns the gene GNRH1 and adenomyosis.